Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H9NO |
Molecular Weight | 123.1525 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCC1=NC=CC=C1
InChI
InChIKey=BXGYBSJAZFGIPX-UHFFFAOYSA-N
InChI=1S/C7H9NO/c9-6-4-7-3-1-2-5-8-7/h1-3,5,9H,4,6H2
Molecular Formula | C7H9NO |
Molecular Weight | 123.1525 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. | 2001 Apr |
|
[[Separation of oxetacaine and its metabolites] ]. | 2001 Jan |
|
Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells. | 2002 Aug 15 |
|
Quantum tunneling of magnetization in a new [Mn18]2+ single-molecule magnet with s = 13. | 2002 Aug 21 |
|
Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol. | 2003 Sep 15 |
|
Large spin differences in structurally related Fe6 molecular clusters and their magnetostructural explanation. | 2004 Sep 6 |
|
Single-molecule magnets: structure and properties of [Mn18O14(O2CMe)18(hep)4(hepH)2(H2O)2](ClO4)2 with spin S = 13. | 2005 Feb 7 |
|
Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers. | 2005 Jun |
|
Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. | 2006 Aug 15 |
|
Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity. | 2006 Mar |
|
Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. | 2007 Apr |
|
Vapor-diffusion-mediated single crystal-to-single crystal transformation of a discrete dimeric copper(II) complex to a discrete tetrameric copper(II) complex. | 2009 Jun 1 |
|
Oxethazaine as the source of mephentermine and phentermine in athlete's urine. | 2009 Mar 10 |
|
2,2'-Diamino-N,N'-(o-phenyl-ene)di-benz-amide. | 2009 Mar 25 |
|
Bis(dicyanamido-κN)bis-[2-(2-hydroxy-ethyl)pyridine-κN,O]nickel(II). | 2009 Nov 7 |
|
Family of Mn(III)(2)Ln(2)(mu(4)-O) compounds: syntheses, structures, and magnetic properties. | 2010 Jun 7 |
|
Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis. | 2010 Mar |
|
Bis[2-(pyridin-2-yl)ethanol-κN,O]bis-(thio-cyanato-κN)nickel(II). | 2010 Nov 17 |
|
Nuclearity of nickel and mixed sodium-nickel complexes: dependence on the spacer in chelating pyridine-alcoholate ligands. | 2010 Sep 21 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Thu Jul 06 13:37:28 UTC 2023
by
admin
on
Thu Jul 06 13:37:28 UTC 2023
|
Record UNII |
4G94J9B8JR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID2044767
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
77979
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
103-74-2
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
203-140-2
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
2144
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
4G94J9B8JR
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
7675
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY | |||
|
5357
Created by
admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|